Elanco Animal Health Incorporated (ELAN) Stock Grade

About Elanco Animal Health Incorporated's fundamentals

Elanco Animal Health is a $11.2 billion specialty pharmaceutical company serving the animal health market with revenue growth of 6.2% year-over-year. The company reported a net loss in its latest annual period, resulting in a negative 4.9% net margin, though it generated positive free cash flow despite the accounting losses. Without a dividend and lacking standard profitability metrics, the company's current financial position reflects a transitional phase typical of businesses managing through restructuring or investment cycles.